ArticleBMC cardiovascular disorders2026
Non-laboratory-based cardiovascular risk assessment: 10-year absolute risk, predicted heart age and intervention requirements in a Nigerian population.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPopulation-based data on cardiovascular disease (CVD) risk burden are essential for effective planning of CVD reduction strategies. There is paucity of such data in Nigerians. We aimed to determine the 10-year absolute CVD risk and heart age profile of adult Nigerians; to identify the most frequent absolute CVD risk-determining factors and the required treatment interventions.
methodsThis was a secondary analysis of data of 3620 adults aged 30-80 years (51% females) from a population-based cross-sectional hypertension survey in Lagos, Nigeria. A non-laboratory-based CVD risk-assessment framework was used to estimate the 10-year absolute CVD risk and predict the heart age profiles. The WHO PEN was used to identify the treatment intervention requirements.
resultsA total of 316 (8.7%) persons, 218 (12.3%) of males and 98 (5.3%) of females had a 10-year absolute CVD risk ≥ 20%, p < 0.0001. Elevated systolic BP (918 (25.4%)) and excess BMI ((overweight: 1072 (29.6%), obesity: 638 (17.6%)) were the most frequent absolute CVD risk determining factors in the population. Excess BMI occurred more frequently in females (p < 0.0001) while the frequency of elevated systolic BP was similar in both sexes (p = 0.091). High excess heart age (EHA) (≥ 5 years) was present in 1531(42.3%) persons; 798 (45.0%) of males and 733 (39.7%) of females, p < 0.0001. Only 521(14.4%) of the total population needed any treatment intervention, compared to 269 (85.1%) of persons with absolute CVD risk ≥ 20%, and 469 (30.6%) with high EHA. Antihypertensive treatment alone (n = 149 (47.2%)) or in combination with statin and aspirin (n = 85 (26.9%)) were the most frequently required interventions in individuals with CVD risk ≥ 20%.
conclusionA significant proportion of our population has high CVD risk. Strategic policies promoting healthy lifestyles, strengthening the health system for focused risk-based screening, and prioritization of treatment interventions could help lower this risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.